Pharmaids Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Pharmaids Pharmaceuticals Ltd. on BSE

Load latest

Pharmaids Pharmaceuticals Ltd.

28 Jul 2023

58.78

1.36%

Board Meeting

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Board Meeting Intimation for Conideration And Approval Of Unaudited Financial …

BSE India

PHARMAIDS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2023 ,inter alia, to consider and approve Unaudited Financial Results for the quarter and three months ended 30th June 2023.

pdf

Pharmaids Pharmaceuticals Ltd.

21 Jul 2023

58.78

1.36%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And …

BSE India

This is to inform you that the company has received request letter from Ms. Abhilekha Jain, member belonging to "Promoter and promoter group" seeking reclassification from "Promoter and promoter group" to "Public shareholders". The request will be reviewed and shall be considered by the Board of Directors of the Company in the forthcoming Board meeting in accordance with provisions of Regulations 31A(8)(A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Pharmaids Pharmaceuticals Ltd.

14 Jul 2023

58.78

1.36%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And …

BSE India

This is t inform you that the Company has received request letter from Mr. Subhash Lalwani, member belonging to "Promoter and promoter group" seeking reclassification from "Promoter and promoter group" to "Public shareholders". The requests wil be reviewed and shall be considered by the Board of Directors of the Company in the forthcoming Board meeting in accordance with provisions of Regulation 31A(8)(A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Pharmaids Pharmaceuticals Ltd.

14 Jul 2023

58.78

1.36%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And …

BSE India

This is to inform you that the company has received request letters from Mr. Subhash B Lalwani, member belonging to "Promoter and promoter group" seeking reclassification from "Promoter and promoter group" to "public shareholders". The requests will be reviewed and shall be considered by the Board of Directors of the Company in the forthcoming Board meeting in accordance with provisions of Regulation 31A(8)(A) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Pharmaids Pharmaceuticals Ltd.

11 Jul 2023

58.78

1.36%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Announcement Under Regulation 31A(8)(A) Of The SEBI (Listing Obligation And …

BSE India

This is to inform you that the Company has received request letters from Veena Lalwani, Abhishek Jain and Ghisulal Jain, members belonging to "Promoter and promoter group" seeking reclassification from "Promoter and Promoter group" to "public shareholders". The requests will be reviewed and shall be considered by the Board of Directors of the Company in the forthcoming Board meeting in accordance with provisions of Regulation 31A(8)(A) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

pdf

Pharmaids Pharmaceuticals Ltd.

05 Jul 2023

58.78

1.36%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Compliance Certificate under Reg. 74(5) of SEBI(DP) Regulations, 2018 for the quarter ended June 30, 2023.

pdf

Pharmaids Pharmaceuticals Ltd.

05 Jul 2023

58.78

1.36%

Corp. Note

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation towards issue of duplicate share certificate under regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Pharmaids Pharmaceuticals Ltd.

30 Jun 2023

58.78

1.36%

SAST

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Closure of Trading Window

BSE India

Pursuant to the Code of Conduct of the company for the prevention of Insider Trading framed under the SEBI( Prohibition of Insider Trading)Regulations, 2015, the Trading window for dealing in the securities of the company by the designated persons and their immediate relatives shall remain closed from July 01st 2023 till the 48 hours after the declaration of the unaudited financial results of the company for the quarter ended 30th June, 2023.

pdf

Pharmaids Pharmaceuticals Ltd.

27 Jun 2023

58.78

1.36%

Company Update

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Intimation Of Submission Of Application To BSE Limited For Reclassification …

BSE India

Intimation of submission of application to BSE Limited for reclassification of promoters of Pharmaids Pharmaceuticals Limited (''Company'') from the ''Promoter and Promoter Group'' category to the ''Public'' category under Regulations 30 and 31A of the Securities and Exchange Board of India (Listing Obligations Disclosure Requirements) Regulations, 2015 (''Listing Regulations'').

pdf

Pharmaids Pharmaceuticals Ltd.

19 Jun 2023

58.78

1.36%

Corp. Note

PHARMAIDS PHARMACEUTICALS LTD. - 524572 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation towards issue of Duplicate Share Certificate under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

pdf

Is Pharmaids Pharmaceuticals Ltd. worth buying?

13 Votes:

Buy 53.85%

Sell 30.77%

Hold 15.38%